21 Feb 2020 --- At a time when cannabidiol (CBD) enjoys market prominence for its therapeutic qualities, but is widely limited by regulation – Brazillian company Beraca introduces an “natural and safe alternative” to the cannabis extract. Beracare CBA (Cannabinoid Active System) is a complex of Amazonian oils marketed as reducing inflammatory activity while stimulating the production of beneficial β-endorphins. Moreover, the company targets the launch of its Açai Extract, further tapping into the graceful aging trend.
